Form D Explorer

Inspect source fieldsReport a record issue

Form D — Everest Biolabs, Inc.

0002116676-26-000001 · filed Mar 11, 2026

Figures are issuer-reported and describe stored filings. Data coverage and methodology.

Check this disclosure on SEC EDGAR · More Biotechnology filings

Offering

Industry
Biotechnology
Exemptions
Rule 506(b)
Reported offering amount
$5,650,000
Reported amount sold
$4,350,000
Minimum investment
$0
Investors
—
Sales commission
—
Finders' fees
—

Issuer

Name
Everest Biolabs, Inc.
CIK
2116676
Entity
Corporation
Jurisdiction
DELAWARE
Year incorporated
2024
Address
204 SECOND AVE
WALTHAM, Massachusetts 02451
Phone
6172140840

Related persons

May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.

View the original filing on SEC EDGAR ↗